Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study (Q41185543)
Jump to navigation
Jump to search
scientific article published on 18 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study |
scientific article published on 18 March 2015 |
Statements
1 reference
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study (English)
1 reference
1 reference
1 reference
Toni K Choueiri
1 reference
Gary D Hammer
1 reference
Martin Fassnacht
1 reference
Eric Baudin
1 reference
Harm Haak
1 reference
Michael J Demeure
1 reference
Alfredo Berruti
1 reference
Jill Gilbert
1 reference
Elizabeth Hesseltine
1 reference
Srinivasu Poondru
1 reference
Tanya Fleege
1 reference
Ramona Rorig
1 reference
Jihong Chen
1 reference
Andrew W Stephens
1 reference
Francis Worden
1 reference
18 March 2015
1 reference
1 reference
16
1 reference
4
1 reference
426-435
1 reference
Identifiers
1 reference
1 reference